β¨ Health Notices
NEW ZEALAND GAZETTE, No. 48
15 MAY 2014
Health
Burial and Cremation Act 1964
Appointment of Manawatu District Council to Have the Control and Management of Rongotea Cemetery
Pursuant to section 23(3) of the Burial and Cremation Act 1964, His Excellency the Governor-General of New Zealand has appointed the Manawatu District Council to have the control and management of the Rongotea Cemetery, being 1.9879 hectares, more or less, being Lot 20A DP 514 and being the land contained in Identifier WN45/62 in the land registration district of Wellington, as from the date of signing.
Dated at Wellington this 30th day of April 2014.
HON TONY RYALL, Minister of Health.
go2840
Medicines Act 1981
Consent to the Distribution of a New Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:
Schedule
Product: Arrow - Clopid
Active Ingredient: Clopidogrel bisulfate 97.875mg equivalent to Clopidogrel 75mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Actavis New Zealand Limited
Manufacturer: Macleods Pharmaceuticals Limited, Himachal Pradesh, India
Dated this 8th day of May 2014.
DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
go2910
Suspension of Consent to the Distribution of Medicines
Pursuant to section 35(1)(b) of the Medicines Act 1981, the Minister of Health hereby suspends consent to the distribution in New Zealand of the following medicines for a period of one year from 15 May 2014:
Schedule
Product: Venlafaxine XR
Active Ingredient: Venlafaxine hydrochloride 84.869mg equivalent to Venlafaxine 75mg
Dosage Form: Modified release capsule
New Zealand Sponsor: PSM Healthcare Limited trading as API Consumer Brands
Manufacturer: Wockhardt Limited, Maharashatra State, India
Product: Venlafaxine XR
Active Ingredient: Venlafaxine hydrochloride 169.738mg equivalent to Venlafaxine 150mg
Dosage Form: Modified release capsule
New Zealand Sponsor: PSM Healthcare Limited trading as API Consumer Brands
Manufacturer: Wockhardt Limited, Maharashatra State, India
Dated this 7th day of May 2014.
DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
go2911
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: 0.9% Sodium Chloride
Active Ingredient: Sodium chloride 9g/L
Dosage Form: Solution for infusion
New Zealand Sponsor: Baxter Healthcare Limited
Manufacturer: Baxter Healthcare Corporation, North Carolina, United States of America
Next Page →
β¨ LLM interpretation of page content
π₯ Appointment of Manawatu District Council to Manage Rongotea Cemetery
π₯ Health & Social Welfare30 April 2014
Cemetery, Control, Management, Rongotea, Manawatu District Council
- HON TONY RYALL, Minister of Health
π₯ Consent to Distribute New Medicine: Arrow - Clopid
π₯ Health & Social Welfare8 May 2014
Medicine, Distribution, Clopidogrel, Arrow - Clopid, Actavis New Zealand Limited
- DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health
π₯ Suspension of Consent to Distribute Venlafaxine XR
π₯ Health & Social Welfare7 May 2014
Medicine, Suspension, Venlafaxine XR, PSM Healthcare Limited, Wockhardt Limited
- DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health
π₯ Consent to Distribute New Medicine: 0.9% Sodium Chloride
π₯ Health & Social WelfareMedicine, Distribution, Sodium Chloride, Baxter Healthcare Limited
NZ Gazette 2014, No 48